Sign up United Kingdom
SkinBioTherapeutics PLC (:SBTX)

SkinBioTherapeutics PLC (:SBTX)

Share Price
19.80 p
0.55 (2.86 %)
Market Cap
£23.50 m
Proactive Investors - Run By Investors For Investors

SkinBioTherapeutics PLC

SkinBioTherapeutics is a life science company focused on skin health. The Company's proprietary platform technology, SkinBiotix®, is based upon discoveries made by CEO Dr. Catherine O'Neill and Professor Andrew McBain at The University of Manchester.

The SkinBioTherapeutics' platform applies research discoveries made on the activities of lysates derived from probiotic bacteria when...

Market: AIM:SBTX
52-week High/Low: 29.93p / 7.07p
Sector: Pharma & Biotech
Market Cap: 23.50M

SkinBioTherapeutics PLC

Interactive graph

col 3
col 4
col 5
col 6

Big picture - Why invest in SkinBioTherapeutics PLC

SkinBioTherapeutics PLC Timeline

The cream has been formulated to contain SkinBioTherapeutics' proprietary technology, SkinBiotix; tests have proved the cream formulation retains the same beneficial properties as the original technology

© Proactive Investors 2018

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use